戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 oxy group, led to the oxatetracyclic core of platensimycin.
2 to develop a concise asymmetric synthesis of platensimycin.
3  and biologically related but different from platensimycin.
4 lay a key role in the biological activity of platensimycin.
5  used in the synthesis of the antibiotic (-)-platensimycin.
6                                              Platensimycin (1a) is a novel broad spectrum Gram-positi
7             An enantioselective synthesis of platensimycin, a novel antibiotic natural product that i
8              Here we report the discovery of platensimycin, a previously unknown class of antibiotics
9 logical evaluation of two distinct series of platensimycin analogues with varying degrees of complexi
10                       The total syntheses of platensimycin and its congeners, platensimycins B(1) and
11                    The secondary metabolites platensimycin and platencin, isolated from the bacterial
12 ydroxyl group in the unified biosynthesis of platensimycin and platencin, two highly functionalized d
13 to the unique diterpene-derived scaffolds of platensimycin and platencin.
14 ate synthase involved in the biosynthesis of platensimycin and platencin.
15 yntheses of platensimycin and its congeners, platensimycins B(1) and B(3), platensic acid, methyl pla
16        Recently we reported the discovery of platensimycin by screening natural product extracts usin
17                                              Platensimycin demonstrates strong, broad-spectrum Gram-p
18                               Treatment with platensimycin eradicates Staphylococcus aureus infection
19 analogue of the recently reported antibiotic platensimycin has been accomplished.
20    Platencin, though structurally similar to platensimycin, has been found to operate through a sligh
21              Direct binding assays show that platensimycin interacts specifically with the acyl-enzym
22 while the substituted benzoic acid domain of platensimycin is a highly conserved structural motif wit
23                                              Platensimycin is the flagship member of a new and growin
24                                              Platensimycin is the most potent inhibitor reported for
25                    Chronic administration of platensimycin led to a net reduction in liver triglyceri
26 ings refine our present understanding of the platensimycin pharmacophore and establish certain struct
27                                              Platensimycin, platencin, and phomallenic acids, newly d
28                                              Platensimycin (PTM) and platencin (PTN) are highly funct
29                                              Platensimycin (PTM) and platencin (PTN) are highly funct
30                                              Platensimycin (PTM) and platencin (PTN) are potent and s
31                                              Platensimycin (PTM) is a recently discovered broad-spect
32        Because of its unique mode of action, platensimycin shows no cross-resistance to other key ant
33 inhibitors of mammalian fatty acid synthase, platensimycin specifically inhibits fatty acid synthesis
34 95 and 3.91 microg/ml, respectively, whereas platensimycin targets only FabF (IC50 = 0.13 microg/ml)